M. Abdoli Shadbad, A. Baghbanzadeh, and B. Baradaran, “hsa-miR-34a-5p enhances temozolomide anti-tumoral effects on glioblastoma: in-silico and in-vitro study”, EXCLI J., vol. 23, pp. 384–400, Mar. 2024.